Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study

J. Dorst,L. Dupuis,S. Petri,K. Kollewe,S. Abdulla,Joachim Wolf,Markus Weber,D. Czell,Christian Burkhardt,F. Hanisch,S. Vielhaber,T. Meyer,G. Frisch,D. Kettemann,T. Grehl

DOI: https://doi.org/10.1007/s00415-015-7646-2

2015-01-25

Journal of Neurology

Abstract:

What problem does this paper attempt to address?

Mitochondria-associated membrane-modulated Ca2+ transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Yingchao Gong,Jun Lin,Zetao Ma,Mei Yu,Meihui Wang,Dongwu Lai,Guosheng Fu

DOI: https://doi.org/10.1016/j.lfs.2021.119511

IF: 6.78

2021-01-01

Life Sciences

Abstract:Effective Ca2+ dependent mitochondrial energy supply is imperative for proper cardiac contractile activity, while disruption of Ca2+ homeostasis participates in the pathogenesis of multiple human diseases. This phenomenon is particularly prominent in cardiac ischemia and reperfusion (I/R) and heart failure, both of which require strict clinical intervention. The interface between endoplasmic reticula (ER) and mitochondria, designated the mitochondria-associated membrane (MAM), is now regarded as a crucial mediator of Ca2+ transportation. Thus, interventions targeting this physical and functional coupling between mitochondria and the ER are highly desirable. Increasing evidence supports the notion that restoration, and maintenance, of the physiological contact between these two organelles can improve mitochondrial function, while inhibiting cell death, thereby sufficiently ameliorating I/R injury and heart failure development. A better understanding regarding the underlying mechanism of MAM-mediated transport will pave the way for identification of novel treatment approaches for heart disease. Therefore, in this review, we summarize the crucial functions and potential mechanisms of MAMs in the pathogenesis of I/R and heart failure.
Mitochondrial calcium regulation of cardiac metabolism in health and disease

Enrique Balderas,Sandra HJ Lee,Neeraj K Rai,David M Mollinedo,Hannah E Duron,Dipayan Chaudhuri

DOI: https://doi.org/10.1152/physiol.00014.2024

IF: 11.8461

2024-05-09

Physiology

Abstract:Oxidative phosphorylation is regulated by mitochondrial calcium (Ca 2+ ) in health and disease. In physiological states, Ca 2+ enters via the mitochondrial Ca 2+ uniporter and rapidly enhances NADH and ATP production. However, maintaining Ca 2+ homeostasis is critical: insufficient Ca 2+ impairs stress adaptation, while Ca 2+ overload can trigger cell death. In this review, we delve into recent insights further defining the relationship between mitochondrial Ca 2+ dynamics and oxidative phosphorylation. Our focus is on how such regulation affects cardiac function in health and disease, including heart failure, ischemia-reperfusion, arrhythmias, catecholaminergic polymorphic ventricular tachycardia, mitochondrial cardiomyopathies, Barth syndrome, and Friedreich's ataxia. Several themes emerge from recent data. First, mitochondrial Ca 2+ regulation is critical for fuel substrate selection, metabolite import, and matching of ATP supply to demand. Second, mitochondrial Ca 2+ regulates both the production and response to reactive oxygen species (ROS), and the balance between its pro- and antioxidant effects is key to how it contributes to physiological and pathological states. Third, Ca 2+ exerts localized effects on the electron transport chain (ETC), not through traditional allosteric mechanisms, but rather indirectly. These effects hinge on specific transporters, such as the uniporter or the Na + -Ca 2+ exchanger and may not be noticeable acutely, contributing differently to phenotypes depending on whether Ca 2+ transporters are acutely or chronically modified. Perturbations in these novel relationships during disease states may either serve as compensatory mechanisms or exacerbate impairments in oxidative phosphorylation. Consequently, targeting mitochondrial Ca 2+ holds promise as a therapeutic strategy for a variety of cardiac diseases characterized by contractile failure or arrhythmias.

physiology
Two components of calcium channel current in embryonic chick skeletal muscle cells developing in culture.

M. Kano,K. Wakuta,R. Satoh

DOI: https://doi.org/10.1016/0165-3806(89)90112-0

1989-05-01

Abstract:
Voltage-dependent Anion Channel Involved in the Mitochondrial Calcium Cycle of Cell Lines Carrying the Mitochondrial DNA A4263G Mutation.

Yuqi Liu,Lei Gao,Qiao Xue,Zongbin Li,Lin Wang,Rui Chen,Mohan Liu,Yi Wen,Minxin Guan,Yang Li,Shiwen Wang

DOI: https://doi.org/10.1016/j.bbrc.2010.11.124

IF: 3.1

2010-01-01

Biochemical and Biophysical Research Communications

Abstract:In this study, we investigated the effects of the voltage-dependent anion channel (VDAC) on the mitochondrial calcium cycle in cell lines carrying the mitochondrial DNA A4263G mutation. We established lymphoblastoid cell lines from three symptomatic individuals and one asymptomatic individual from the large Chinese Han family carrying the A4263G mutation; these were compared with three control cell lines. The mitochondrial Ca2+ concentration and membrane potential were detected by loading cells with Rhod-2 and JC-1, respectively. Confocal imagines showed the average Rhod-2 and JC-1 fluorescence levels of individuals carrying the tRNA(Ile) A4263G mutation were lower than those of the control group (P < 0.05). The baseline Rhod-2 fluorescence in the control group increased after exposure to atractyloside (an opener of the adenine nucleotide translocator, P < 0.05), but no significant change was detected in the cell line harboring the A4263G mutation (P > 0.05). The baseline JC-1 fluorescence in both the mutated and control cell lines decreased after subsequent exposure to atractyloside (P < 0.05), whereas this effect of atractyloside was inhibited by Cyclosporin A (CsA, a VDAC blocker). We conclude that the mitochondrial VDAC is involved in both the increase of mitochondrial permeability to Ca2+ and the decrease of mitochondrial membrane potential in cell lines carrying the mtDNA A4263G mutation. (C) 2010 Elsevier Inc. All rights reserved.
MICU1 and MICU2 control mitochondrial calcium signaling in the mammalian heart

Prottoy Hasan,Elena Berezhnaya,Macarena Rodríguez-Prados,David Weaver,Carmen Bekeova,Benjamin Cartes-Saavedra,Erin Birch,Andreas M Beyer,Janine H Santos,Erin L Seifert,John W Elrod,György Hajnóczky

DOI: https://doi.org/10.1073/pnas.2402491121

2024-08-27

Abstract:Activating Ca2+-sensitive enzymes of oxidative metabolism while preventing calcium overload that leads to mitochondrial and cellular injury requires dynamic control of mitochondrial Ca2+ uptake. This is ensured by the mitochondrial calcium uptake (MICU)1/2 proteins that gate the pore of the mitochondrial calcium uniporter (mtCU). MICU1 is relatively sparse in the heart, and recent studies claimed the mammalian heart lacks MICU1 gating of mtCU. However, genetic models have not been tested. We find that MICU1 is present in a complex with MCU in nonfailing human hearts. Furthermore, using murine genetic models and pharmacology, we show that MICU1 and MICU2 control cardiac mitochondrial Ca2+ influx, and that MICU1 deletion alters cardiomyocyte mitochondrial calcium signaling and energy metabolism. MICU1 loss causes substantial compensatory changes in the mtCU composition and abundance, increased turnover of essential MCU regulator (EMRE) early on and, later, of MCU, that limit mitochondrial Ca2+ uptake and allow cell survival. Thus, both the primary consequences of MICU1 loss and the ensuing robust compensation highlight MICU1's relevance in the beating heart.
Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications

Hai-xia Xu,Su-mei Cui,Ying-mei Zhang,Jun Ren

DOI: https://doi.org/10.1038/s41401-020-0476-5

IF: 7.169

2020-07-21

Acta Pharmacologica Sinica

Abstract:Heart failure (HF) represents one of the leading causes of cardiovascular diseases with high rates of hospitalization, morbidity and mortality worldwide. Ample evidence has consolidated a crucial role for mitochondrial injury in the progression of HF. It is well established that mitochondrial Ca2+ participates in the regulation of a wide variety of biological processes, including oxidative phosphorylation, ATP synthesis, reactive oxygen species (ROS) generation, mitochondrial dynamics and mitophagy. Nonetheless, mitochondrial Ca2+ overload stimulates mitochondrial permeability transition pore (mPTP) opening and mitochondrial swelling, resulting in mitochondrial injury, apoptosis, cardiac remodeling, and ultimately development of HF. Moreover, mitochondria possess a series of Ca2+ transport influx and efflux channels, to buffer Ca2+ in the cytoplasm. Interaction at mitochondria-associated endoplasmic reticulum membranes (MAMs) may also participate in the regulation of mitochondrial Ca2+ homeostasis and plays an essential role in the progression of HF. Here, we provide an overview of regulation of mitochondrial Ca2+ homeostasis in maintenance of cardiac function, in an effort to identify novel therapeutic strategies for the management of HF.

pharmacology & pharmacy,chemistry, multidisciplinary
The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy

M Panel,L Fossier,M Lacote,L Luong-Azria,A C Meli,P Sicard,J Thireau,A Lacampagne,J Fauconnier

DOI: https://doi.org/10.1093/cvr/cvae088.110

IF: 13.081

2024-05-31

Cardiovascular Research

Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): ANR Introduction Calcium (Ca2+) uptake by the mitochondrial Ca2+ uniporter complex (MCUC) controls key steps of oxidative metabolism to adapt energy production to cardiac demand. To ensure this critical function, MCUC assembly and maturation is a tightly regulated process involving the AAA proteases. We recently demonstrated that mitochondrial Ca2+ uptake is impaired during the early stages of metabolic cardiomyopathy in the atria. Purpose Our aim was to investigate mitochondrial Ca2+ handling in the left ventricle during the early stages of metabolic cardiomyopathy and to characterize the mechanisms underlying the functional remodeling of the MCUC. Methods Male C57Bl6/J mice were fed a high-fat sucrose diet (HFS) for two weeks to induce metabolic cardiomyopathy. Mitochondrial Ca2+ uptake was then studied (1) in isolated ventricular cardiomyocytes using whole-cell patch-clamp coupled with confocal microscopy and (2) in isolated mitochondria using Ca2+ Green-5N. The biophysical properties of MCUC were recorded in a planar lipid bilayer. MCUC structure and AAA-proteases expression were assessed by Western blot and co-immunoprecipitation. Control mice were treated with AAV9 harboring shRNA to downregulate the expression of MAIP1. Results Metabolic cardiomyopathy was associated with reduced beat-to-beat mitochondrial Ca2+ uptake in ventricular cardiomyocytes, which was further confirmed in isolated mitochondria. Single-channel recordings of the native cardiac MCUC embedded in a planar lipid bilayer revealed a reduction in ionic conductance and open probability, demonstrating functional impairment of the MCUC. Biochemical analysis of the MCUC revealed an accumulation of the unprocessed form of the EMRE subunit and a decreased interaction of the EMRE-MICU1 subcomplex with the pore-forming MCU subunits, indicating a structural remodeling of the MCUC. The expression of the AAA proteases YME1L and AFG3L2/SPG7, which are responsible for EMRE maturation and insertion into the MCUC, was unchanged. However, the expression of m-AAA protease-interacting protein 1 (MAIP1), which orchestrates EMRE processing, was reduced. In control mice, shRNA-mediated downregulation of MAIP1 recapitulated the structural and functional changes of the MCUC. Conclusions The structural remodeling of the MCUC integrity by downregulation of its assembly affects mitochondrial Ca2+ homeostasis in the early stages of metabolic cardiomyopathy. MAIP1 is a key regulator of MCUC assembly and its downregulation underlies the functional remodeling of the MCUC. These findings provide a novel post-translational paradigm of MCUC regulation in pathophysiology and suggest novel therapeutic targets for the treatment of the metabolic cardiomyopathy.

cardiac & cardiovascular systems
The Mitochondrial Calcium Uniporter (MCU): Molecular Identity and Role in Human Diseases

Donato D’Angelo,Rosario Rizzuto,Donato D'Angelo

DOI: https://doi.org/10.3390/biom13091304

IF: 6.064

2023-08-25

Biomolecules

Abstract:Calcium (Ca2+) ions act as a second messenger, regulating several cell functions. Mitochondria are critical organelles for the regulation of intracellular Ca2+. Mitochondrial calcium (mtCa2+) uptake is ensured by the presence in the inner mitochondrial membrane (IMM) of the mitochondrial calcium uniporter (MCU) complex, a macromolecular structure composed of pore-forming and regulatory subunits. MtCa2+ uptake plays a crucial role in the regulation of oxidative metabolism and cell death. A lot of evidence demonstrates that the dysregulation of mtCa2+ homeostasis can have serious pathological outcomes. In this review, we briefly discuss the molecular structure and the function of the MCU complex and then we focus our attention on human diseases in which a dysfunction in mtCa2+ has been shown.

biochemistry & molecular biology
Unravelling the complexity of the mitochondrial Ca 2+ uniporter: regulation, tissue specificity, and physiological implications

Denis Vecellio Reane,Julian D.C. Serna,Anna Raffaello

DOI: https://doi.org/10.1016/j.ceca.2024.102907

IF: 4.69

2024-05-25

Cell Calcium

Abstract:Calcium (Ca 2+ ) signalling acts a pleiotropic message within the cell that is decoded by the mitochondria through a sophisticated ion channel known as the Mitochondrial Ca 2+ Uniporter (MCU) complex. Under physiological conditions, mitochondrial Ca 2+ signalling is crucial for coordinating cell activation with energy production. Conversely, in pathological scenarios, it can determine the fine balance between cell survival and death. Over the last decade, significant progress has been made in understanding the molecular bases of mitochondrial Ca 2+ signalling. This began with the elucidation of the MCU channel components and extended to the elucidation of the mechanisms that regulate its activity. Additionally, increasing evidence suggests molecular mechanisms allowing tissue-specific modulation of the MCU complex, tailoring channel activity to the specific needs of different tissues or cell types. This review aims to explore the latest evidence elucidating the regulation of the MCU complex, the molecular factors controlling the tissue-specific properties of the channel, and the physiological and pathological implications of mitochondrial Ca 2+ signalling in different tissues.

cell biology
Mechanisms and significance of tissue-specific MICU regulation of the mitochondrial calcium uniporter complex

Chen-Wei Tsai,Madison X. Rodriguez,Anna M. Van Keuren,Charles B. Phillips,Hannah M. Shushunov,Jessica E. Lee,Anastacia M. Garcia,Amrut V. Ambardekar,Joseph C. Cleveland,Julie A. Reisz,Catherine Proenza,Kathryn C. Chatfield,Ming-Feng Tsai

DOI: https://doi.org/10.1016/j.molcel.2022.09.006

IF: 16

2022-10-06

Molecular Cell

Abstract:Mitochondrial Ca2+ uptake, mediated by the mitochondrial Ca2+ uniporter, regulates oxidative phosphorylation, apoptosis, and intracellular Ca2+ signaling. Previous studies suggest that non-neuronal uniporters are exclusively regulated by a MICU1-MICU2 heterodimer. Here, we show that skeletal-muscle and kidney uniporters also complex with a MICU1-MICU1 homodimer and that human/mouse cardiac uniporters are largely devoid of MICUs. Cells employ protein-importation machineries to fine-tune the relative abundance of MICU1 homo- and heterodimers and utilize a conserved MICU intersubunit disulfide to protect properly assembled dimers from proteolysis by YME1L1. Using the MICU1 homodimer or removing MICU1 allows mitochondria to more readily take up Ca2+ so that cells can produce more ATP in response to intracellular Ca2+ transients. However, the trade-off is elevated ROS, impaired basal metabolism, and higher susceptibility to death. These results provide mechanistic insights into how tissues can manipulate mitochondrial Ca2+ uptake properties to support their unique physiological functions.

cell biology,biochemistry & molecular biology
The mitochondrial calcium uniporter is a highly selective ion channel

Yuriy Kirichok,Grigory Krapivinsky,David E. Clapham

DOI: https://doi.org/10.1038/nature02246

IF: 64.8

2004-01-01

Nature

Abstract:During intracellular Ca2+ signalling mitochondria accumulate significant amounts of Ca2+ from the cytosol1,2. Mitochondrial Ca2+ uptake controls the rate of energy production1,3,4, shapes the amplitude and spatio-temporal patterns of intracellular Ca2+ signals1,5,6,7,8, and is instrumental to cell death9,10. This Ca2+ uptake is undertaken by the mitochondrial Ca2+ uniporter (MCU) located in the organelle's inner membrane11,12. The uniporter passes Ca2+ down the electrochemical gradient maintained across this membrane without direct coupling to ATP hydrolysis or transport of other ions11. Carriers are characterized by turnover numbers that are typically 1,000-fold lower than ion channels, and until now it has been unclear whether the MCU is a carrier or a channel13. By patch-clamping the inner mitochondrial membrane, we identified a previously unknown Ca2+-selective ion channel sensitive to inhibitors of mitochondrial Ca2+ uptake. Our data indicate that this unique channel binds Ca2+ with extremely high affinity (dissociation constant ≤2 nM), enabling high Ca2+ selectivity despite relatively low cytoplasmic Ca2+ concentrations. The channel is inwardly rectifying, making it especially effective for Ca2+ uptake into energized mitochondria. Thus, we conclude that the properties of the current mediated by this novel channel are those of the MCU.

multidisciplinary sciences
MICU1 and MICU2, two peas in a pod or entirely different fruits?

Jiuzhou Huo,Jeffery D. Molkentin

DOI: https://doi.org/10.1016/j.ceca.2024.102959

IF: 4.69

2024-10-10

Cell Calcium

Abstract:Fluctuations in mitochondrial matrix Ca 2+ plays a critical role in matching energy production to cellular demand through direct effects on oxidative phosphorylation and ATP production. Disruption in mitochondrial Ca 2+ homeostasis, particularly under pathological conditions such as ischemia or heart failure, can lead to mitochondrial dysfunction, energy deficit, and eventually death of cardiomyocytes. The primary channel regulating acute mitochondrial Ca 2+ influx is the mitochondrial Ca 2+ uniporter (mtCU), which is regulated by the mitochondrial Ca 2+ uptake (MICU) proteins that were examined here.

cell biology
Assessment of Cardiac Function in Mice Lacking the Mitochondrial Calcium Uniporter.

Kira M. Holmstroem,Xin Pan,Julia C. Liu,Sara Menazza,Jie Liu,Tiffany T. Nguyen,Haihui Pan,Randi J. Parks,Stasia Anderson,Audrey Noguchi,Danielle Springer,Elizabeth Murphy,Toren Finkel

DOI: https://doi.org/10.1016/j.yjmcc.2015.05.022

IF: 5.763

2015-01-01

Journal of Molecular and Cellular Cardiology

Abstract:Mitochondrial calcium is thought to play an important role in the regulation of cardiac bioenergetics and function. The entry of calcium into the mitochondrial matrix requires that the divalent cation pass through the inner mitochondrial membrane via a specialized pore known as the mitochondrial calcium uniporter (MCU). Here, we use mice deficient of MCU expression to rigorously assess the role of mitochondrial calcium in cardiac function. Mitochondria isolated from MCU−/− mice have reduced matrix calcium levels, impaired calcium uptake and a defect in calcium-stimulated respiration. Nonetheless, we find that the absence of MCU expression does not affect basal cardiac function at either 12 or 20months of age. Moreover, the physiological response of MCU−/− mice to isoproterenol challenge or transverse aortic constriction appears similar to control mice. Thus, while mitochondria derived from MCU−/− mice have markedly impaired mitochondrial calcium handling, the hearts of these animals surprisingly appear to function relatively normally under basal conditions and during stress.
MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors

Macarena Rodríguez-Prados,Kai-Ting Huang,Katalin Márta,Melanie Paillard,György Csordás,Suresh K Joseph,György Hajnóczky

DOI: https://doi.org/10.1016/j.chembiol.2023.05.002

2023-06-15

Abstract:Mitochondrial Ca2+ homeostasis loses its control in many diseases and might provide therapeutic targets. Mitochondrial Ca2+ uptake is mediated by the uniporter channel (mtCU), formed by MCU and is regulated by the Ca2+-sensing gatekeeper, MICU1, which shows tissue-specific stoichiometry. An important gap in knowledge is the molecular mechanism of the mtCU activators and inhibitors. We report that all pharmacological activators of the mtCU (spermine, kaempferol, SB202190) act in a MICU1-dependent manner, likely by binding to MICU1 and preventing MICU1's gatekeeping activity. These agents also sensitized the mtCU to inhibition by Ru265 and enhanced the Mn2+-induced cytotoxicity as previously seen with MICU1 deletion. Thus, MCU gating by MICU1 is the target of mtCU agonists and is a barrier for inhibitors like RuRed/Ru360/Ru265. The varying MICU1:MCU ratios result in different outcomes for both mtCU agonists and antagonists in different tissues, which is relevant for both pre-clinical research and therapeutic efforts.
Mechanism of MCUB-dependent inhibition of mitochondrial calcium uptake

Neeraj K. Rai,Anthony M. Balynas,Melissa JS MacEwen,Ashley R. Bratt,Yasemin Sancak,Dipayan Chaudhuri

DOI: https://doi.org/10.1101/2024.11.25.625228

2024-11-26

Abstract:Mitochondrial Ca levels are regulated to balance stimulating respiration against the harm of Ca overload. Contributing to this balance, the main channel transporting Ca into the matrix, the mitochondrial Ca uniporter, can incorporate a dominant-negative subunit (MCUB). MCUB is homologous to the pore-forming subunit MCU, but when present in the pore-lining tetramer, inhibits Ca transport. Here, using cell lines deleted of both MCU and MCUB, we identify three factors that contribute to MCUB-dependent inhibition. First, MCUB protein requires MCU to express. The effect is mediated via the N-terminal domain (NTD) of MCUB. Replacement of the MCUB NTD with the MCU NTD recovers autonomous expression but fails to rescue Ca uptake. Surprisingly, mutations to MCUB that affect interactions with accessory subunits or the conduction pore all failed to rescue Ca uptake, suggesting the mechanism of inhibition may involve global rearrangements. Second, using concatemeric tetramers with varying MCU:MCUB ratios, we find that MCUB incorporation does not abolish conduction, but rather inhibits Ca influx proportional to the amount of MCUB present in the channel. Reducing rather than abolishing Ca transport is consistent with MCUB retaining the highly-conserved selectivity filter DIME sequence. Finally, we apply live-cell Förster resonance energy transfer to establish that the endogenous stoichiometry is 2:2 MCU:MCUB. Taken together, our results suggest MCUB preferentially incorporates into nascent uniporters, and the amount of MCUB protein present linearly correlates with the degree of inhibition of Ca transport, creating a precise, tunable mechanism for cells to regulate mitochondrial Ca uptake.

Cell Biology
The Function of Mitochondrial Calcium Uniporter at the Whole-Cell and Single Mitochondrion Levels in WT, MICU1 KO, and MICU2 KO Cells

Syed Islamuddin Shah,Ghanim Ullah

DOI: https://doi.org/10.3390/cells9061520

IF: 6

2020-06-22

Cells

Abstract:Mitochondrial Ca2+ ([Ca2+]M) uptake through its Ca2+ uniporter (MCU) is central to many cell functions such as bioenergetics, spatiotemporal organization of Ca2+ signals, and apoptosis. MCU activity is regulated by several intrinsic proteins including MICU1, MICU2, and EMRE. While significant details about the role of MICU1, MICU2, and EMRE in MCU function have emerged recently, a key challenge for the future experiments is to investigate how these regulatory proteins modulate mitochondrial Ca2+ influx through MCU in intact cells under pathophysiological conditions. This is further complicated by the fact that several variables affecting MCU function change dynamically as cell functions. To overcome this void, we develop a data-driven model that closely replicates the behavior of MCU under a wide range of cytosolic Ca2+ ([Ca2+]C), [Ca2+]M, and mitochondrial membrane potential values in WT, MICU1 knockout (KO), and MICU2 KO cells at the single mitochondrion and whole-cell levels. The model is extended to investigate how MICU1 or MICU2 KO affect mitochondrial function. Moreover, we show how Ca2+ buffering proteins, the separation between mitochondrion and Ca2+-releasing stores, and the duration of opening of Ca2+-releasing channels affect mitochondrial function under different conditions. Finally, we demonstrate an easy extension of the model to single channel function of MCU.

cell biology
MCU complex: Exploring emerging targets and mechanisms of mitochondrial physiology and pathology

Jin Wang,Jinyong Jiang,Haoliang Hu,Linxi Chen

DOI: https://doi.org/10.1016/j.jare.2024.02.013

IF: 12.822

2024-02-01

Journal of Advanced Research

Abstract:BACKGROUND: Globally, the onset and progression of multiple human diseases are associated with mitochondrial dysfunction and dysregulation of Ca2+ uptake dynamics mediated by the mitochondrial calcium uniporter (MCU) complex, which plays a key role in mitochondrial dysfunction. Despite relevant studies, the underlying pathophysiological mechanisms have not yet been fully elucidated.AIM OF REVIEW: This article provides an in-depth analysis of the current research status of the MCU complex, focusing on its molecular composition, regulatory mechanisms, and association with diseases. In addition, we conducted an in-depth analysis of the regulatory effects of agonists, inhibitors, and traditional Chinese medicine (TCM) monomers on the MCU complex and their application prospects in disease treatment. From the perspective of medicinal chemistry, we conducted an in-depth analysis of the structure-activity relationship between these small molecules and MCU and deduced potential pharmacophores and binding pockets. Simultaneously, key structural domains of the MCU complex in Homo sapiens were identified. We also studied the functional expression of the MCU complex in Drosophila, Zebrafish, and Caenorhabditis elegans. These analyses provide a basis for exploring potential treatment strategies targeting the MCU complex and provide strong support for the development of future precision medicine and treatments.KEY SCIENTIFIC CONCEPTS OF REVIEW: The MCU complex exhibits varying behavior across different tissues and plays various roles in metabolic functions. It consists of six MCU subunits, an essential MCU regulator (EMRE), and solute carrier 25A23 (SLC25A23). They regulate processes, such as mitochondrial Ca2+ (mCa2+) uptake, mitochondrial adenosine triphosphate (ATP) production, calcium dynamics, oxidative stress (OS), and cell death. Regulation makes it a potential target for treating diseases, especially cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic diseases, and tumors.

multidisciplinary sciences
Clinical Nurse Specialist Practice in a Care Coordination Model

C. Tringali,Tamara H Murphy,MARY LOU Osevala

DOI: https://doi.org/10.1097/01.NUR.0000325368.61668.35

2008-09-01

Abstract:The goal of care coordination is to facilitate and enhance positive patient outcomes. The contribution that the clinical nurse specialist (CNS) can make toward the achievement of this goal is supported in the literature. The CNS can impact patient outcomes by influencing nursing practice and organizational systems for the delivery of quality, cost-effective patient care. These CNS practice activities can be uniquely tailored to specialty populations. Three CNSs within the Department of Care Coordination report how they have developed their own individual practices within their distinct specialties. Although the approach varied, the outcomes of influencing the quality of nursing care, patient education, and safe, uncomplicated transition from the hospital to next disposition were the same.
Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart

Tyler P. Rasmussen,Yuejin Wu,Mei-ling A. Joiner,Olha M. Koval,Nicholas R. Wilson,Elizabeth D. Luczak,Qinchuan Wang,Biyi Chen,Zhan Gao,Zhiyong Zhu,Brett A. Wagner,Jamie Soto,Michael L. McCormick,William Kutschke,Robert M. Weiss,Liping Yu,Ryan L. Boudreau,E. Dale Abel,Fenghuang Zhan,Douglas R. Spitz,Garry R. Buettner,Long-Sheng Song,Leonid V. Zingman,Mark E. Anderson

DOI: https://doi.org/10.1073/pnas.1504705112

IF: 11.1

2015-07-07

Proceedings of the National Academy of Sciences

Abstract:Significance Mitochondrial Ca 2+ is a fundamental signal that allows for adaptation to physiological stress but a liability during ischemia-reperfusion injury in heart. On one hand, mitochondrial Ca 2+ entry coordinates energy supply and demand in myocardium by increasing the activity of matrix dehydrogenases to augment ATP production by oxidative phosphorylation. On the other hand, inhibiting mitochondrial Ca 2+ overload is promulgated as a therapeutic approach to preserve myocardial tissue following ischemia-reperfusion injury. We developed a new mouse model of myocardial-targeted transgenic dominant-negative mitochondrial Ca 2+ uniporter (MCU) expression to test consequences of chronic loss of MCU-mediated Ca 2+ entry in heart. Here we show that MCU inhibition has unanticipated consequences on extramitochondrial pathways affecting oxygen utilization, cytoplasmic Ca 2+ homeostasis, physiologic responses to stress, and pathologic responses to ischemia-reperfusion injury.
Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling

Dejiu Zhang,Fei Wang,Peifeng Li,Yanyan Gao

DOI: https://doi.org/10.3390/ijms23063025

IF: 5.6

2022-03-11

International Journal of Molecular Sciences

Abstract:Mitochondria are the sites of oxidative metabolism in eukaryotes where the metabolites of sugars, fats, and amino acids are oxidized to harvest energy. Notably, mitochondria store Ca2+ and work in synergy with organelles such as the endoplasmic reticulum and extracellular matrix to control the dynamic balance of Ca2+ concentration in cells. Mitochondria are the vital organelles in heart tissue. Mitochondrial Ca2+ homeostasis is particularly important for maintaining the physiological and pathological mechanisms of the heart. Mitochondrial Ca2+ homeostasis plays a key role in the regulation of cardiac energy metabolism, mechanisms of death, oxygen free radical production, and autophagy. The imbalance of mitochondrial Ca2+ balance is closely associated with cardiac remodeling. The mitochondrial Ca2+ uniporter (mtCU) protein complex is responsible for the uptake and release of mitochondrial Ca2+ and regulation of Ca2+ homeostasis in mitochondria and consequently, in cells. This review summarizes the mechanisms of mitochondrial Ca2+ homeostasis in physiological and pathological cardiac remodeling and the regulatory effects of the mitochondrial calcium regulatory complex on cardiac energy metabolism, cell death, and autophagy, and also provides the theoretical basis for mitochondrial Ca2+ as a novel target for the treatment of cardiovascular diseases.

biochemistry & molecular biology,chemistry, multidisciplinary

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitochondrial calcium regulation of cardiac metabolism in health and disease

Two components of calcium channel current in embryonic chick skeletal muscle cells developing in culture.

Voltage-dependent Anion Channel Involved in the Mitochondrial Calcium Cycle of Cell Lines Carrying the Mitochondrial DNA A4263G Mutation.

MICU1 and MICU2 control mitochondrial calcium signaling in the mammalian heart

Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications

The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy

The Mitochondrial Calcium Uniporter (MCU): Molecular Identity and Role in Human Diseases

Unravelling the complexity of the mitochondrial Ca 2+ uniporter: regulation, tissue specificity, and physiological implications

Mechanisms and significance of tissue-specific MICU regulation of the mitochondrial calcium uniporter complex

The mitochondrial calcium uniporter is a highly selective ion channel

MICU1 and MICU2, two peas in a pod or entirely different fruits?

Assessment of Cardiac Function in Mice Lacking the Mitochondrial Calcium Uniporter.

MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors

Mechanism of MCUB-dependent inhibition of mitochondrial calcium uptake

The Function of Mitochondrial Calcium Uniporter at the Whole-Cell and Single Mitochondrion Levels in WT, MICU1 KO, and MICU2 KO Cells

MCU complex: Exploring emerging targets and mechanisms of mitochondrial physiology and pathology

Clinical Nurse Specialist Practice in a Care Coordination Model

Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart

Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling